Retractable Needle Safety Syringes Market in Germany is set to exhibit a CAGR of 4.1% during the forecast period
NEWARK, DE / ACCESSWIRE / August 24, 2022 / As per Future Market Insights' latest industry analysis, the global retractable needle safety syringes market was valued at around US$ 5.49 Bn in 2021 and is anticipated to reach US$ 8.45 Bn by 2032, exhibiting a CAGR of around 4.0% over the forecast period (2022-2032).
In the retractable needle safety syringes, as soon as the plunger handle is fully depressed, the needle is immediately drawn back from the patient and into the syringe's barrel. Pre-removal automatic retraction practically eliminates exposure to the contaminated needle, thus lowering the chance of needle stick injuries.
Major technological developments related to needles and syringes, such as the introduction of retractable needle safety syringes, lubrication technology and needle-stick safety-equipped devices, have increased the demand for retractable needle safety syringes in the market.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15450
In addition to this, development of various safety devices, such as a passive needle guard with an advanced retractable needle system and plastic shield is largely addressing the issue of needle-stick injuries. Thus, technological advancement will continue to play a key role in spurring growth of the retractable needle safety syringes market.
Furthermore, organizations and manufacturers with advanced procurement functions have opportunity to grow and expand their business to purchasers and traders. Together they work to develop innovative products in order to boost revenues and profits for both parties. They are using different key strategies, such as new product launches, expansion, and collaborations, among others to expand their footprint.
For instance, in June 2021, the space Medtech start-up ResearchSat partnered with the subsidiary of Numedico Technologies Pty Ltd. (Numedico Science Pty Ltd.), to work together for developing innovative therapies and drugs delivery based systems.
Key Takeaways from Market Study
By product, manual retractable safety syringes are expected to hold around 62.1% market value share by the end of 2032.
By application, intravenous segment holds a market share value of around 45.0%.
By end-user, hospitals segment accounted for the highest market share value of 38.7% in 2021.
North America accounted for around 33.4% revenue share of the global retractable needle safety syringes market in 2021.
The retractable needle safety syringes market in Germany is set to expand at 4.1% CAGR during the forecast period.
Demand for retractable needle safety syringes in China to increase at a CAGR of 4.2% over the next ten years.
Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-15450
"With increasing advancement in retractable needle safety syringes and surge in needle stick injury cases, growth in the retractable needle safety syringes market is on the cards," as per the analyst of Future Market Insights.
Acquisition among the companies or brands is the key strategy of the retractable needle safety syringe manufacturers such as Becton, Dickinson and Company, Cardinal Health, and Nipro Corporation to grow their presence in the market and compete with other competitors during the coming years. Following are a few examples of acquisitions made by them to be at the top position:
In November 2020, BD acquired the medical business assets of CUBEX LLC, broadening its automated dispensing portfolio across the care continuum.
In January 2019, Cardinal Health announced the acquisition of Mirixa Corporation, a leading organization in developing solutions for medication therapy management.
In February 2021, Terumo Corporation announced the acquisition of Health Outcomes Sciences, Inc.
Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2012 to 2032. The global retractable needle safety syringes market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on retractable needle safety syringes market segment based on Product - (Manual Retractable Safety Syringe and Auto-retractable Safety Syringe), By Application (Subcutaneous, Intramuscular, and Intravenous) By End User - (Hospitals, Clinics, Ambulatory Surgical Centres and Others), By Distribution Channel (Direct to Customer, Retail (Retail Pharmacies and Drug Stores) and Online Pharmacies) across seven major regions.
Request Methodology@ https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15450
Key Market Segments Covered in Retractable Needle Safety Syringes Industry Research
The Middle East and Africa (MEA)
Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-15450
About Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.
1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations
2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions
3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends
4.1. Product Adoption / Usage Analysis 4.2. Product USPs / Features 4.3. Key Promotional Strategies, by Market Players 4.4. Regulatory Scenario 4.5. PESTLE Analysis 4.6. Porter's Analysis
Have a Look at Related Research Reports of Healthcare
Retractable Needles Market Size: Retractable Needles market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape Cardiovascular Needle Market Share: The global market for cardiovascular needles is expected to grow moderately over the forecast period of 2016-2026 due to replacement of traditional procedure with surgical staples' use High Flow Needle Sets Market Trends: The global market for high flow needle sets was valued at US$ 12.5 Billion in 2021, and is likely to be valued at US$ 14 Billion in 2022, reflecting a Y-o-Y growth rate of 12%. GCC Syringes and Needles Market Analysis: The GCC Syringes and Needles Market was valued at US$ 525.4 Mn in 2020 and is expected to reach US$ 1.33 Bn by 2031, registering a CAGR of 8.8% over the forecast period, from 2021 to 2031 Special Purpose Needles Market Outlook: Special purpose needles are used in target specific drug deliveries or collection of samples such as fluid and cells from organs or lumps and are available in the market with various advanced features, shapes, and size Biosimilars And Biologics market Share : The biosimilars and biologics market size is estimated to reach a valuation of US$ 22,490.62 Mn in 2022 with a CAGR of 15.5% during the forecast period. The market is likely to reach US$ 95,021.37 Mn by 2032. Hydrokinetic Fibre Dressings Market Demand : The global hydrokinetic fibre dressings market is expected to be valued at US$ 164.2 Million in 2022, expected to reach US$ 251.1 Million by 2032. A CAGR worth 3.9% is expected for the market during the 2022-2032 forecast period. Canine Flu Therapeutics Market Type : The canine flu therapeutics market is projected to have a slow-paced CAGR of 4.1% during the forecast period. The current valuation of the canine flu therapeutics market is US$ 1975.4 million in 2022. Cervical Spacer Systems Market Forecast : In 2022, the global cervical spacer systems market is expected to be worth US$ 361 Million. By 2032, the market is expected to grow to US$ 744.1 Million. Complex Regional Pain Syndrome (CRPS) Market Analysis : The global market for complex regional pain syndrome (CRPS) is estimated to be worth US$ 101.9 Million in 2022, rising to US$ 126.7 Million by 2032.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/retractable-needle-safety-syringes-market For Sales Enquiries: sales@futuremarketinsights.com Browse latest Market Reports: https://www.futuremarketinsights.com/reports
SOURCE: Future Market Insights Inc.
View source version on accesswire.com: https://www.accesswire.com/713322/Retractable-Needle-Safety-Syringes-Market-to-Surpass-US-845-Bn-by-2032-Amid-Increasing-Prevalence-of-Chronic-Diseases-Future-Market-Insights-Inc
Federated Hermes Chief Equity Strategist Phil Orlando joins Yahoo Finance Live to discuss Jerome Powell's latest comments and what the next steps from the Fed may be to fight inflation.
WASHINGTON (Reuters) -Global shipping container suppliers China International Marine Containers and Maersk Container Industry in a joint statement on Thursday said they have abandoned a merger plan, citing significant regulatory challenges. China International Marine Containers (CIMC) in September had agreed to buy the Danish shipping company AP Moeller - Maersk's refrigerated containers maker for $987.3 million. The U.S. Justice Department said the deal would have combined two of the world's four suppliers of refrigerated shipping containers and further concentrated the global cold supply chain.
Follow Buffett’s lead. And collect big dividends while you’re at it.
Though signs point to prices moderating, Powell said on Friday that the bank will continue to hike interest rates this year
WASHINGTON (Reuters) -The U.S. government said on Thursday it will suspend 26 China-bound flights from the United States by four Chinese carriers in response to the Chinese government's decision to suspend some U.S. carrier flights over COVID-19 cases. The decision will affect flights by Xiamen, Air China, China Southern Airlines and China Eastern Airlines from Sept. 5 to Sept. 28. The U.S. Department of Transportation (USDOT) cited the recent cancellation of 26 American Airlines, Delta Air Lines and United Airlines flights over COVID-19 cases.
Canadian cannabis stocks are under pressure yet again today. As of 1:12 p.m. ET Friday, Tilray (NASDAQ: TLRY) stock was down by 5.4%, Canopy Growth's (NASDAQ: CGC) equity was in the red by 7.3%, and Aurora Cannabis' (NASDAQ: ACB) shares were lower by 7%. Yesterday, Democratic Sen. Ron Wyden admitted in comments to public policy magazine The American Prospect that the Cannabis Administration and Opportunity Act (CAOA) is unlikely to have the 60 votes required to pass.
Yahoo Finance's Dan Howley discusses reports that the DOJ is drafting an antitrust suit against Apple and what that means for rival tech companies like Google.
(Bloomberg) -- An outage at the largest US Midwest refinery is raising wholesale fuel prices regionally just as the agricultural sector gears up for its busiest time of year. Most Read from BloombergGOP Fury Over ESG Triggers Backlash With US Pensions at RiskNearly 60,000 Sneakers in $85 Million Ponzi Scheme to Go on SaleKorea Shatters Its Own Record for World’s Lowest Fertility RateA 129-Foot Superyacht Worth Millions Sinks Off the Italian CoastSix Months of Putin’s War Unravels Russia’s Superp
Altria Group (MO) declares a dividend hike of 4.4%, taking its quarterly dividend to 94 cents per share. The company is focused on boosting shareholders' returns.
As these catalysts are not likely to subside any time soon, natural gas prices could remain elevated at levels not seen since 2008. Here are three stocks related to natural gas exploration, production and distribution, and also pay high dividends to shareholders. ONE Gas Inc. is one of the largest publicly traded natural gas utilities in the United States.
The chip maker has lost a third of its value in 2022. Its CEO just made his biggest buy of shares since becoming CEO early last year.
The old stock market axiom to buy when others are fearful could readily apply right now, according to Ashish Shah, chief investment officer at Goldman Sachs. Amid concerns markets will be volatile following Federal Reserve Chair Jerome Powell’s Jackson Hole policy speech on Friday, Shah thinks that doesn’t mean investors should stay on the sidelines at present. It's preferable to buy "when there's fear in the market," say Shah. "Don't fall into the trap of buying when there's FOMO," he added. Ag
California will ban the sale of internal combustion engine passenger cars by 2035, officials there said on Aug. 24. The policy, coming on top of new incentives for EV buyers in the Inflation Reduction Act, could dramatically reshape the entire US vehicle fleet. California is the country’s biggest vehicle market, and more than a dozen states copy its emissions standards.
In this article, we discuss Bill Gates’ top 10 dividend stocks. You can skip our detailed analysis of the Bill & Melinda Gates Foundation’s performance, and go directly to read Bill Gates Portfolio: Top 5 Dividend Stock Picks. Bill & Melinda Gates Foundation was established in 2000 with the purpose to improve the well-being of […]
Yahoo Finance's Ines Ferre breaks down Friday's market action, with stocks closing at the lows of the session and the U.S. dollar rising.
Yahoo Finance's Jared Blikre breaks down how the tech sector is trading on Friday afternoon after Federal Reserve Chair Jerome Powell delivered remarks in Jackson Hole, Wyoming.
Nio (NYSE: NIO) investors got some good news from Chinese authorities for the second day in a row today. The company's American depositary shares are responding again this morning, jumping 6% at the market open but easing to a gain of 1.9% as of 10:05 a.m. ET. Shares of the Chinese EV company spiked yesterday on news that the Chinese government was adding a new stimulus package to jump-start a sagging economy.
Beijing offered a rare concession Friday, agreeing to allow U.S. accounting regulators to examine the audits of Chinese firms listed on American stock exchanges.
Skyrocketing prices for natural gas have Europeans scrambling for alternative energy sources.In Germany, where households face a 480 euro rise in their gas bills, people are resorting to stockpiling firewood.
(Bloomberg) -- 3M Co. lost its fight to block jury trials in more than 230,000 lawsuits accusing it of harming US soldiers. The company’s shares fell on the ruling.Most Read from BloombergNearly 60,000 Sneakers in $85 Million Ponzi Scheme to Go on SaleGOP Fury Over ESG Triggers Backlash With US Pensions at RiskWorld’s Most Popular Password Manager Says It Was HackedTrump’s Stash at Mar-a-Lago Included Highly Classified DocumentsA 129-Foot Superyacht Worth Millions Sinks Off the Italian CoastUS B